Trial Profile
Rapid Activity of Platelet Inhibitor Drugs Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Oct 2014
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor
- Indications Embolism and thrombosis; Myocardial infarction
- Focus Pharmacodynamics
- Acronyms RAPID
- 24 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jan 2012 New trial record